Talimogene laherparepvec
Drug timelines are a Plus or Pro feature.
15 regulatory and trial events tracked for Talimogene laherparepvec, covering 2015-12-17 to 2025-02-24. Get the full timeline:
Most recent: Clinical Trial Update: Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma [Phase 2]